Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,662,932
-$513,028 QoQ
Shares Held
11,084
-52.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#274
of 596 holders
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Atom Investors LP holds $5,388,940 across 6 Diagnostics & Research names. GH ranks #1 (30.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
This page
|
11,084 | $1,662,932 | |
| 2 | RVTY |
Revvity, Inc.
|
11,804 | $1,313,313 | |
| 3 | WGS |
GeneDx Holdings Corp.
|
10,697 | $734,349 | |
| 4 | VCYT |
Veracyte, Inc.
|
12,104 | $710,867 | |
| 5 | PSNL |
Personalis, Inc.
|
40,763 | $546,224 | |
| 6 | FLGT |
Fulgent Genetics, Inc.
|
20,529 | $421,255 |
All Filings in GH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,662,932 | 11,084 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,175,960 | 23,557 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,081,919 | 20,383 | Shares | Sole | 2026-02-17 | |
| 2024-03-31 | $273,677 | 13,266 | Shares | Sole | 2024-05-15 | |
| 2020-12-31 | $1,982,174 | 15,380 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,558,213 | 13,940 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,786,337 | 46,670 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||